FDA approved new Alzheimer’s drug shown to slow cognitive decline in patients in the early stages of the illness.
You May Also Like
The fight over whether courts can ban mifepristone is headed back to the Supreme Court
- August 16, 2023
A cabinet containing boxes of mifepristone, seen in Wellspring Health Access clinic in Casper, Wyoming. | Rachel Woolf/Washington…
More families are facing prescription drug price shocks, even for lifesaving children’s medications
- January 8, 2023
Children’s EpiPens and other lifesaving medications may not be covered if families have high-deductible health insurance plans.
Could a third-party candidate actually derail Biden?
- July 17, 2023
Senator Joe Manchin, a Democrat from West Virginia, during a community listening session at Piketon High School in…
California cleans up from one storm as it prepares for another – CNN
- January 15, 2023
California cleans up from one storm as it prepares for another CNN ‘Extremely dangerous’ storm dumps more rain, snow…
McCarthy to meet with Taiwanese president in visit China calls a ‘provocation’
- April 3, 2023
House Speaker Kevin McCarthy, R-Calif., will meet Wednesday with Taiwanese President Tsai Ing-Wen in a summit that China…
Canada and the U.S. both face labor shortages. One country is increasing immigration.
- January 7, 2023
To address a looming labor shortage, Canada plans to accept 1.45 million immigrants by 2025. The U.S. faces…